![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1623954 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of GCC2 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | RGD:1305732 | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of GCC2 mRNA | CTD | PMID:26496021 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1623954 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GCC2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1305732 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCC2 mRNA | CTD | PMID:32109520 | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of GCC2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of GCC2 mRNA | CTD | PMID:32699268 | aflatoxin B1 | increases expression | ISO | RGD:1623954 | 6480464 | Aflatoxin B1 results in increased expression of GCC2 mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of GCC2 mRNA | CTD | PMID:23724009 | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of GCC2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of GCC2 mRNA | CTD | PMID:32699268 | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of GCC2 mRNA | CTD | PMID:22521957 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzoapyrene results in increased methylation of GCC2 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | benzo[b]fluoranthene | increases expression | ISO | RGD:1623954 | 6480464 | benzobfluoranthene results in increased expression of GCC2 mRNA | CTD | PMID:26377693 | bisphenol A | multiple interactions | ISO | RGD:1305732 | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of GCC2 mRNA, [bisphenol A co-treated with tributyltin] results in increased expression of GCC2 mRNA | CTD | PMID:26496021, PMID:31129395 | bisphenol A | decreases expression | ISO | RGD:1305732 | 6480464 | bisphenol A results in decreased expression of GCC2 mRNA | CTD | PMID:30816183 | bisphenol A | affects expression | ISO | RGD:1305732 | 6480464 | bisphenol A affects the expression of GCC2 mRNA | CTD | PMID:25181051 | cadmium dichloride | decreases expression | ISO | RGD:1623954 | 6480464 | Cadmium Chloride results in decreased expression of GCC2 mRNA | CTD | PMID:24982889 | chloroprene | increases expression | ISO | RGD:1305732 | 6480464 | Chloroprene results in increased expression of GCC2 mRNA | CTD | PMID:23125180 | clorgyline | increases expression | EXP | | 6480464 | Clorgyline results in increased expression of GCC2 mRNA | CTD | PMID:19691856 | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of GCC2 mRNA | CTD | PMID:19376846 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of GCC2 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | RGD:1623954 | 6480464 | Cyclosporine results in decreased expression of GCC2 mRNA | CTD | PMID:19770486 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of GCC2 mRNA | CTD | PMID:25562108 | DDT | decreases expression | ISO | RGD:1305732 | 6480464 | DDT results in decreased expression of GCC2 mRNA | CTD | PMID:30207508 | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of GCC2 mRNA | CTD | PMID:22521957 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of GCC2 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GCC2 mRNA | CTD | PMID:27188386 | ethanol | affects splicing | ISO | RGD:1623954 | 6480464 | Ethanol affects the splicing of GCC2 mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of GCC2 mRNA | CTD | PMID:23649840 | flutamide | increases expression | ISO | RGD:1305732 | 6480464 | Flutamide results in increased expression of GCC2 mRNA | CTD | PMID:24136188 | folic acid | decreases expression | ISO | RGD:1623954 | 6480464 | Folic Acid results in decreased expression of GCC2 mRNA | CTD | PMID:25629700 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of GCC2 mRNA | CTD | PMID:23649840 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of GCC2 mRNA | CTD | PMID:23649840 | oxaliplatin | multiple interactions | ISO | RGD:1305732 | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of GCC2 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of GCC2 mRNA more ... | CTD | PMID:32699268 | paracetamol | affects expression | ISO | RGD:1623954 | 6480464 | Acetaminophen affects the expression of GCC2 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GCC2 mRNA | CTD | PMID:21420995 | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of GCC2 mRNA | CTD | PMID:27153767 | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of GCC2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GCC2 mRNA | CTD | PMID:27188386 | potassium dichromate | decreases expression | ISO | RGD:1623954 | 6480464 | Potassium Dichromate results in decreased expression of GCC2 mRNA | CTD | PMID:23608068 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:1623954 | 6480464 | Pregnenolone Carbonitrile results in increased expression of GCC2 mRNA | CTD | PMID:22698814 | Propiverine | affects binding | ISO | RGD:1305732 | 6480464 | propiverine binds to GCC2 protein | CTD | PMID:29273565 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GCC2 mRNA | CTD | PMID:27188386 | serpentine asbestos | increases expression | EXP | | 6480464 | Asbestos, Serpentine results in increased expression of GCC2 mRNA | CTD | PMID:21148743 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of GCC2 mRNA | CTD | PMID:25895662 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of GCC2 mRNA | CTD | PMID:28595984 | tetrachloromethane | increases expression | ISO | RGD:1623954 | 6480464 | Carbon Tetrachloride results in increased expression of GCC2 mRNA | CTD | PMID:31919559 | tetraphene | increases expression | ISO | RGD:1623954 | 6480464 | benzaanthracene results in increased expression of GCC2 mRNA | CTD | PMID:26377693 | topotecan | multiple interactions | ISO | RGD:1305732 | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of GCC2 mRNA | CTD | PMID:25729387 | tributylstannane | multiple interactions | ISO | RGD:1305732 | 6480464 | [bisphenol A co-treated with tributyltin] results in increased expression of GCC2 mRNA | CTD | PMID:31129395 | valproic acid | affects expression | ISO | RGD:1623954 | 6480464 | Valproic Acid affects the expression of GCC2 mRNA | CTD | PMID:17963808 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of GCC2 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of GCC2 mRNA | CTD | PMID:25979313 | valproic acid | affects splicing | ISO | RGD:1305732 | 6480464 | Valproic Acid affects the splicing of GCC2 mRNA | CTD | PMID:29427782 | |